Breast tissue microarrays facilitate the survey of very large numbers of tumours but their scoring by pathologists is time consuming, typically highly quantised and not without error. Automated segmentation of cells and intra-cellular compartments in such data can be problematic for reasons that include cell overlapping, complex tissue structure, debris, and variable appearance. This paper proposes a computationally efficient approach that uses colour and differential invariants to assign class posterior probabilities to pixels and then performs probabilistic classification of TMA spots using features analogous to the Quickscore system currently used by pathologists. It does not rely on accurate segmentation of individual cells. Classificat...
Morphological analysis of the appearance and quantity of cells and tissue architecture has been rout...
Copyright © 2013 C. Loukas et al.This is an open access article distributed under theCreativeCommons...
The harbinger of a far more lethal and difficult-to-treat disease, early breast cancer is a key, but...
Breast-tissue microarrays facilitate the survey of very large numbers of tumours but their scoring b...
Tissue microarrays (TMAs) facilitate the survey of very large numbers of tumours. However, the manua...
Breast tissue microarrays (TMAs) facilitate the study of very large numbers of breast tumours in a s...
Abstract Background Tissue MicroArray technology aims to perform immunohistochemical staining on hun...
Breast tissue microarrays (TMAs) facilitate the study of very large numbers of breast tumours per hi...
Automated tissue image analysis aims to develop algorithms for a variety of histological application...
In the research of cancer biomarker and cell signaling pathways, multiple immunofluorescence labell...
Background: The Human Protein Atlas (HPA) is an effort to map the location of all human proteins (ht...
Background: Microarray analysis represents a powerful way to test scientific hypotheses on the funct...
Tissue microarrays (TMAs) are an important tool in translational research for examining multiple can...
Rapid assessment of tissue biopsies is a critical issue in modern histopathology. For breast cancer ...
<div><p>Breast cancer diagnosis is still done by observation of biopsies under the microscope. The d...
Morphological analysis of the appearance and quantity of cells and tissue architecture has been rout...
Copyright © 2013 C. Loukas et al.This is an open access article distributed under theCreativeCommons...
The harbinger of a far more lethal and difficult-to-treat disease, early breast cancer is a key, but...
Breast-tissue microarrays facilitate the survey of very large numbers of tumours but their scoring b...
Tissue microarrays (TMAs) facilitate the survey of very large numbers of tumours. However, the manua...
Breast tissue microarrays (TMAs) facilitate the study of very large numbers of breast tumours in a s...
Abstract Background Tissue MicroArray technology aims to perform immunohistochemical staining on hun...
Breast tissue microarrays (TMAs) facilitate the study of very large numbers of breast tumours per hi...
Automated tissue image analysis aims to develop algorithms for a variety of histological application...
In the research of cancer biomarker and cell signaling pathways, multiple immunofluorescence labell...
Background: The Human Protein Atlas (HPA) is an effort to map the location of all human proteins (ht...
Background: Microarray analysis represents a powerful way to test scientific hypotheses on the funct...
Tissue microarrays (TMAs) are an important tool in translational research for examining multiple can...
Rapid assessment of tissue biopsies is a critical issue in modern histopathology. For breast cancer ...
<div><p>Breast cancer diagnosis is still done by observation of biopsies under the microscope. The d...
Morphological analysis of the appearance and quantity of cells and tissue architecture has been rout...
Copyright © 2013 C. Loukas et al.This is an open access article distributed under theCreativeCommons...
The harbinger of a far more lethal and difficult-to-treat disease, early breast cancer is a key, but...